Literature DB >> 18841867

Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe.

Mitsuhiro Nakamura1, Yuichiro Narita, Yukinori Matsuo, Masaru Narabayashi, Manabu Nakata, Shinsuke Yano, Yuki Miyabe, Kiyotomo Matsugi, Akira Sawada, Yoshiki Norihisa, Takashi Mizowaki, Yasushi Nagata, Masahiro Hiraoka.   

Abstract

Since stereotactic body radiotherapy (SBRT) was started for patients with lung tumor in 1998 in our institution, x-ray fluoroscopic examination and slow computed tomography (CT) scan with a rotation time of 4 s have been routinely applied to determine target volumes. When lung tumor motion observed with x-ray fluoroscopy is larger than 8 mm, diaphragm control (DC) is used to reduce tumor motion during respiration. After the installation of a four-dimensional (4D) CT scanner in 2006, 4D CT images have been supplementarily acquired to determine target volumes. It was found that target volumes based on slow CT images were substantially different from those on 4D CT images, even for patients with lung tumor motion no larger than 8 mm. Although slow CT scan might be expected to fare well for lung tumors with motion range of 8 mm or less, the potential limitations of slow CT scan are unknown. The purpose of this study was to evaluate the geometrical differences in target volumes between slow CT and 4D CT imaging for lung tumors with motion range no larger than 8 mm in the upper and middle lobe. Of the patients who underwent SBR between October 2006 and April 2008, 32 patients who had lung tumor with motion range no larger than 8 mm and did not need to use DC were enrolled in this study. Slow CT and 4D CT images were acquired under free breathing for each patient. Target volumes were manually delineated on slow CT images (TV(slow CT)). Gross tumor volumes were also delineated on each of the 4D CT volumes and their union (TV(4D CT)) was constructed. Volumetric and statistical analyses were performed for each patient. The mean +/- standard deviation (S.D.) of TV(slow CT)/TV(4D CT) was 0.75 +/- 0.17 (range, 0.38-1.10). The difference between sizes of TV(slow CT) and TV(4D CT) was not statistically significant (P = 0.096). A mean of 8% volume of TV(slow CT) was not encompassed in TV(4D CT) (mean +/- S.D. = 0.92 +/- 0.07). The patients were separated into two groups to test whether the quality of target delineation on slow CT scans depends on respiratory periods below or above the CT rotation time of 4 s. No significant difference was observed between these groups (P = 0.229). Even lung tumors with motion range no larger than 8 mm might not be accurately depicted on slow CT images. When only a single slow CT scan was used for lung tumors with motion range of 8 mm or less, 95% confidence values for additional margins for TV(slow CT) to encompass TV(4D CT) were 4.0, 5.4, 4.9, 5.1, 1.8, and 1.7 mm for lateral, medial, ventral, dorsal, cranial, and caudal directions, respectively.

Entities:  

Mesh:

Year:  2008        PMID: 18841867     DOI: 10.1118/1.2968096

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  12 in total

1.  An alternative approach to GTV margin determination in stereotactic body radiotherapy.

Authors:  José Bea-Gilabert; M Carmen Baños-Capilla; M Ángeles García-Martínez; Enrique López-Muñoz; Luis M Larrea-Rabassa
Journal:  J Radiosurg SBRT       Date:  2019

2.  A comparison of the different 3D CT scanning modes on the GTV delineation for the solitary pulmonary lesion.

Authors:  Dong-ping Shang; Cheng-xin Liu; Yong Yin
Journal:  Radiat Oncol       Date:  2014-11-12       Impact factor: 3.481

3.  Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital.

Authors:  Hideomi Yamashita; Wataru Takahashi; Akihiro Haga; Satoshi Kida; Naoya Saotome; Keiichi Nakagawa
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

4.  Analysis of the advantage of individual PTVs defined on axial 3D CT and 4D CT images for liver cancer.

Authors:  Fengxiang Li; Jianbin Li; Jun Xing; Yingjie Zhang; Tingyong Fan; Min Xu; Dongping Shang; Tonghai Liu; Jinlong Song
Journal:  J Appl Clin Med Phys       Date:  2012-11-08       Impact factor: 2.102

5.  Measurement of gantry rotation time in modern ct.

Authors:  Atsushi Fukuda; Pei-Jan P Lin; Kosuke Matsubara; Tosiaki Miyati
Journal:  J Appl Clin Med Phys       Date:  2014-01-06       Impact factor: 2.102

6.  Geometrical differences in gross target volumes between 3DCT and 4DCT imaging in radiotherapy for non-small-cell lung cancer.

Authors:  Fengxing Li; Jianbin Li; Yingjie Zhang; Min Xu; Dongping Shang; Tingyong Fan; Tonghai Liu; Qian Shao
Journal:  J Radiat Res       Date:  2013-04-05       Impact factor: 2.724

7.  The feasibility of evaluating radiation dose to the heart by integrating kilovoltage-cone beam computed tomography in stereotactic body radiotherapy of early non-small-cell lung cancer patients.

Authors:  Chengxin Liu; Guanzhong Gong; Chen Guo; Tonghai Liu; Jie Lu; Hong Zhao; Wei Dong; Yong Yin
Journal:  Radiat Oncol       Date:  2013-12-26       Impact factor: 3.481

8.  Reconstitution of internal target volumes by combining four-dimensional computed tomography and a modified slow computed tomography scan in stereotactic body radiotherapy planning for lung cancer.

Authors:  Seong Soon Jang; Gil Ja Huh; Suk Young Park; Po Song Yang; Hae Nam Chung; Jae Hyuk Seo; Ji Chan Park; Young Jun Yang; Eun Youn Cho
Journal:  Radiat Oncol       Date:  2014-05-02       Impact factor: 3.481

9.  The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer.

Authors:  Wambaka Ange Mampuya; Yukinori Matsuo; Nami Ueki; Mitsuhiro Nakamura; Nobutaka Mukumoto; Akira Nakamura; Yusuke Iizuka; Takahiro Kishi; Takashi Mizowaki; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2014-05-06       Impact factor: 2.724

10.  High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.

Authors:  Won Il Jang; Mi-Sook Kim; Sun Hyun Bae; Chul Koo Cho; Hyung Jun Yoo; Young Seok Seo; Jin-Kyu Kang; So Young Kim; Dong Han Lee; Chul Ju Han; Jin Kim; Su Cheol Park; Sang Bum Kim; Eung-Ho Cho; Young Han Kim
Journal:  Radiat Oncol       Date:  2013-10-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.